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Introduction 
Theophylline anhydrous has been widely used as a 
bronchodilator for the treatment of chronic asthma. The 
bronchodilator effect of theophylline increases with 
serum concentration over a range 5 to 20 µ ml
-1
 but, at a 
plasma level above 20 µg ml
-1
 there is an increased risk 
of toxic effects.
1
 The desirability of maintaining 
theophylline plasma levels within this narrow range had 
led to the development of several controlled release 
formulations.  
Conventional and sustained released dosage forms of 
theophylline with different doses have been formulated 
and marketed. It is clear from investigations that there 
are fluctuations between plasma concentrations in 
sustained released  given once daily and conventional 
dosage forms given several times daily with respect to 
their bioavailability and bronchodilator effect.  
Solvent evaporation method is the preparation technique 
that is widely preferred for the preparation of controlled 
release microspheres. The first stage of this method is to 
A B S T R A C T                                                A R T I C L E   I N F O                            
Introduction: The purpose of this investigation was to evaluate microencapsulated 
controlled release preparation of theophylline using Eudragit RS 100 as the retardant 
material with high entrapment efficiency. Methods: Microspheres were prepared by the 
emulsion-solvent evaporation method. A mixed solvent system consisting of methanol and 
acetone and light liquid paraffin as oily phase were chosen. Sucrose stearate was used as 
the surfactant to stabilize the emulsification process. The prepared microspheres were 
characterized by drug loading, Fourier-transform infrared spectroscopy (FTIR), differential 
scanning colorimetry (DSC) and scanning electron microscopy (SEM). The in vitro release 
studies were performed at pH 1.2 and 7.4 aqueous medium. Results: Increasing the 
concentration of emulsifier, sucrose fatty acid ester F-70, decreased the particle size which 
contributed to increased drug release rate. The drug loading microparticle Eudragit 
RS100(1:6) showed 60-75% of entrapment and mean particle size 205.93-352.76 µm.The 
results showed that, an increase in the ratio of polymer: drug (F5, 6: 1) resulted in a 
reduction in the release rate of the drug which may be attributed to the hydrophobic nature 
of the polymer. Conclusion: The release of theophylline is influenced by the drug to 
polymer ratio and particle size. Drug release is controlled by diffusion and the best-fit 
release kinetic is Higuchi model. 
Keywords: 
Microspheres 
Eudragit RS 100 
Theophylline anhydrous 
Ester sucrose 
Article History: 
Received: 1 February 2011 
Accepted: 5 July 2011 
ePublished: 30 July  2011  
Article Type: 
Research Article 
 |19 Advanced Pharmaceutical Bulletin, 2011, 1(1), 18-26 Copyright © 2011 by Tabriz University of Medical Sciences 
Jelvehgari et  al. 
prepare emulsion by adding the dispersed phase 
consisting of the drug, polymer and appropriate 
dispersion agent in the organic solvent to dispersion 
medium which is immiscible with the dispersed phase. 
At the second stage, minimatrix forms are obtained by 
removing the solvent used at the dispersed phase from 
the droplets which are formed in the emulsion. The 
selection of the organic solvents is done according to the 
polarity of dispersion medium and their dielectric 
constants related too miscibility with dispersion 
medium.
2-5
 
Eudragit RS 100 is a copolymer of acrylic and 
methacrylic acid esters containing 5% of functional 
quaternary ammonium groups. Since Eudragit RS 100 
contains the ammonium groups its permeability is pH 
independent. 
2
 
Dispersing agents can be various polymeric materials, 
proteins, or surfactants, which simplify the formation of 
microspheres by decreasing the interfacial tension 
between the lipophilic and hydrophilic phases.
6 
The 
dispersing agent forms a thin protective layer around the 
droplets and hence reduces the extent of their collision 
and coalescence.
6 
Sucrose esters have been proposed as 
dispersing agents because of the advantages of low 
toxicity and biodegradation. According to earlier studies, 
the droplet stabilizer, sucrose stearate, was used to 
produce nicardipine-Eudragit RS100 microspheres by 
the evaporation method.
7
 
In the present study, emulsion-solvent evaporation 
technique was used to prepare a sustained-release system 
of theophylline. The influence of several factors on 
various physical characteristics, including particle size, 
drug loading, and dissolution properties of the resulting 
microspheres were investigated. 
 
Materials and Methods 
Theophylline anhydrous (Merck, Germany), Edragit RS 
100 (RÖhm Pharma GMBh, Weiterstadt, Germany), 
Sucrose stearate (Crodesta F70) (Croda GmbH, Mettelal, 
Germany). All solvents and reagents were of analytical 
grade.   
 
Experimental Methods 
The solubility of theophylline in various organic solvents 
was measured by adding excess amount of drug to 10 ml 
of solvents. The resulting drug suspension was agitated 
for 24 h at room temperature in glass vials sealed with 
Teflon-lined closure. These samples were centrifuged 
and filtered (0.45 µ nylon filter millipore). An aliquot of 
the filtrate was weighted and diluted appropriately for 
UV spectrophotometer measurement. 
 
Preparation of microspheres 
Microspheres were prepared by solvent evaporation 
method.
7, 8
 A mixture of acetone and methanol (3:1 ratio) 
used as common solvent of theophylline and polymer. 
Theophylline and Eudragit RS 100 were dissolved 
completely in common solvent consisting of acetone and 
methanol (3:1 ratio) by stirring at 500 rpm with magnetic 
stirrer.  Sucrose stearate was added to the resulting 
mixture and sonicated for complete dispersion. This 
mixture was cooled to 10 C in an ice bath while stirring 
at 500 rpm. The resulting mixture was poured into the 
liquid paraffin previously cooled to 10 C. After 
agitation at 400 rpm by 10 ºC the resulting emulsion was 
heated to 35 

C gradually (1 ºC/min) and stirred at this 
temperature for 4h. During this period acetone and 
methanol were removed by evaporation. The solidified 
microspheres were filtered, washed six times with 50 ml 
of n-hexane, dried under vacuum at a room temperature 
for 12 h and stored in desiccators containing CaCl2.
2
 
The effect of the process variables such as drug: polymer 
ratio, stirring rate, emulsifier concentration and volume 
of dispersing medium (liquid paraffin) on the mean 
particle size of the microparticles were investigated. 
Theophylline microspheres were prepared using various 
drug: polymer ratios (1:2, 1:3 …and 1:6), while keeping 
the other variables (stirring rate of 400 rpm, emulsifier 
concentration 3% w/v, volume of  dispersing medium 
200 ml) constant. Similarity to determine the effect of 
stirring rate on the mean particle size of microparticles, 
microspheres were prepared at various stirring rates 
(200, 400 and 600 rpm), while keeping the drug: 
polymer ratio at 1:6, emulsifier concentrations at 3%, 
solvent volume at 15 ml and liquid paraffin volume at 
200 ml (Table 1). 
Microspheres were also prepared using different 
emulsifier concentration of ester sucrose (1, 3 and 5% 
w/v) while keeping the drug: polymer ratio at 1:6 (drug: 
polymer ratio. Three microspheres were prepared that 
the amount of dispersing medium (outer phase, O2), was 
varied (100, 200 and 300 ml), while keeping the other 
variables constant as F5 microspheres. 
 
Determination of drug loading and loading efficiency 
Drug amount in microspheres was determined by 
dissolving 10 mg of each sample in 10 ml of methanol. 
The drug concentration was determined 
spectrophotometrically (UV-160, Shimadzu, Japan) at 
212 nm.  
The loading efficiency (%) was calculated according to 
the following equation: 
Loading efficiency (%) = (actual drug content in 
microparticles/theoretical drug content) × 100 
The production yield of the microparticles was 
determined by calculating accurately the initial weight of 
the raw materials and the final weight of the 
microspheres obtained.
3,9
 All of the experiments were 
performed in triplicate. 
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 Table 1. Anhydrous theophylline microsphere formulations prepared by Emulsion Solvent Evaporation Method (ESE) 
Formulations 
 
Drug: Polymer 
ratio 
Emulsion(O1/O2) 
Internal organic phase (O1) 
External oily 
phase (O2) 
Theophylline 
(g) 
Eudragit 
RS 100 
(g) 
Sucrose 
stearate 
(%) 
acetone 
(ml) 
Methanol 
(ml) 
Liquid 
paraffin 
(ml) 
 
F1 
F2 
F3 
F4 
F5 
 
1:2 
1:3 
1:4 
1:5 
1:6 
1.5 
1.5 
1.5 
1.5 
1.5 
3 
4.5 
6 
7.5 
9 
3 
3 
3 
3 
3 
 
11.5 
19 
26.5 
34 
41.5 
3.5 
3.5 
3.5 
3.5 
3.5 
200 
200 
200 
200 
200 
 
 
Viscosity measurement 
A Brookfield rotational digital viscometer DVLV-II was 
used to measure the viscosity (cP) of the internal 
(dispersed) and external phases (continuous phase) at 10 
◦
C. Spindle numbers 1 was rotated at 100 rpm for this 
measurement. 
 
X-ray Powder diffractometry (X-RPD) 
X-ray diffraction analysis was performed with a 
(Siemens D5000, Munich, Germany) using nickel-
filtered CuKα radiation (a voltage of 40 KV and a 
current of 20 mA). The scanning rate was 2˚/min over a 
2θ range of 20-60˚ and with an interval of 0.02˚. 
 
Differential Scanning Calorimetry (DSC) 
Typically, about 5 mg of sample was weighed into an 
aluminum pan, the pan crimped non-hermetically, and 
heated in the differential scanning calorimeter (DSC 60, 
Shimadzu, Japan) from 30 to 300 ˚C at a rate of 10 ˚C 
per min.  
 
Fourier-Transform Infrared spectroscopy (FTIR) 
The infrared spectrum of the drug, microspheres 
containing the drug were obtained in potassium bromide 
discs (0.5% w/w) using a FTIR spectrophotometer 
(Bomen Hartmann & Brann, Canada). 
 
Particle size analysis and morphological studies 
A laser light scattering particle size analyzer (SALD-
2101, Shimadzu, Japan) was used to determine the 
particle size of the drug and microparticulate 
formulations. Samples were suspended in distilled water 
in a 1 cm cuvette and stirred continuously during the 
particle size analysis. The morphology of microparticles 
was examined with a scanning electron microscope 
(LEO 440i, England) operating at 15 kV. The samples 
were mounted on a metal stub with double adhesive tape 
and coated with platinum/palladium alloy under vacuum.  
 
In vitro release study 
A drug release test was carried out using a dissolution 
tester (USP basket method) at 37 ˚C and 100 rpm. 900 
milliliters of simulated gastric fluid (pH 1.2) and 
phosphate buffer (pH 7.4) were equilibrated at 37±0.5 
˚C. Polysorbate 80 (0.02%, w/v) was added to each 
dissolution media to improve the wetting of the 
microspheres. Microspheres (200 mg drug) and tablet 
were placed in the apparatus and 3 ml aliquots of 
medium were withdrawn at pre-set times over 2h and 
replaced by 3 ml of fresh medium. The samples were 
filtered through 0.45 µm filters and used for the 
spectroscopic determination of the drug. After 2h, 17 ml 
of 0.2 M phosphate buffer stock, pre-equilibrated at 37 
˚C, were added to the dissolution vessel. The pH was 
immediately adjusted, if necessary, with 0.2N HCl or 
0.2N NaOH to pH 7.4 .
2
 
Drug concentration in the samples was measured by UV 
spectrophotometric analysis at 206 and 203 nm for the 
acidic and enteric buffers, respectively. Each experiment 
was repeated three times.   
 
Results and discussion 
 
Solubility of drug in organic solvent  
According to Mehta et al., solubility of drug and 
polymer in the organic solvent determines the 
solidification rate of the polymer during the 
microparticle preparation process, which in turn affects 
microparticle properties such as drug incorporation, 
matrix porosity, and solvent residues.
10,11
 
In order to find suitable solvent, the solubility of 
Theophylline in various solvents was determined and the 
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results are shown in Table 2. Theophylline anhydrous 
was soluble in polar solvents such as ethanol and 
methanol.  
Table 2. Solubility of anhydrous theophylline in various solvents 
Solvent                                        solubility (mg/ml) 
 
Dichloromethane                                       0.91 
 
Isopropyl alcohol                                       1.04 
 
Acetonitrile                                               0.784 
 
Ethanol                                                      15.19 
 
Methanol                                                   0.699 
 
Acetone                                                     3.142 
 
Preparation of microparticles 
Microspheres were formed after a series of steps like 
solvent extraction and solvent evaporation. Microspheres 
were prepared by emulsion solvent evaporation method 
using different polymer-drug ratios (2: 1, 3: 1 … and 6: 
1) (Table 1).  The drug encapsulation efficiency was 
high 60-75% and the production yield values were over 
90%. The encapsulation efficiency of the drug depended 
on the solubility of the drug in the solvent and 
continuous phase.
12
 Theophylline is insoluble in liquid 
paraffin (continuous phase) and encapsulation efficiency 
of microspheres was high. Scanning electron 
microscopic photographs of microspheres (as F5) are 
shown in  Figure 1. 
 
 
Figure 1. SEM of a spherical microspheres containing 
anhydrous theophylline F5 (drug: polymer ratio 1:6) at 50x. 
The size of the prepared microspheres was in the range 
of 248-375 µm (Table 3). Table 3 shows that the ratio of 
polymer to drug plays an important role in the particle 
size of microspheres. As the ratio of polymer: drug is 
increased, particle size is decreased. Increase of polymer 
concentration resulted in a significant decrease (10 cPs) 
in the viscosity of dispersed phase, leading to smaller 
emulsion droplet size and finally smaller particle size. 
Similar observation has been reported for verapamil 
microspheres.
2
 At high polymer: drug ratio the amount 
of drug per microspheres was low.  Volume-based size 
distribution of drug, polymer, and drug loaded 
microspheres indicated a log–probability distribution. 
 
Physical Characterization 
X-ray diffraction patterns of the microspheres containing 
increasing polymer ratios are presented in Figure 2. DSC 
thermograms of microspheres are shown in Figure 3. 
The endothermic peaks demonstrate a reduction in the 
intensity. The endotherm peak of pure drug was 
observed at 61.68°C (Figure 3).  
All prominent absorption bands of the drug were 
unchanged in the FT-IR spectra of the microspheres 
(Figure 4). 
 
 
Figure 2. DSC thermogram of anhydrous theophylline, Eudragit 
RS100, physical mixture F5 (1:6 drug and polymer ratio) and 
different microsphere formulations. 
Effect of formulation variables on the micromeritics 
properties of microspheres 
The effect of drug: polymer ratio, the stirring rate, 
emulsifier concentration and volume of dispersing 
medium on the mean particle size of theophylline 
microspheres is shown in Table 3. In order to investigate 
the effect of stirring rate on the physical properties of 
theophylline microspheres, formulation F5 (1:6 drug: 
polymer ratio) was chosen and the stirring rate altered in 
the range of 200-600 rpm. The dispersion of the internal 
phase of drug and polymer into the droplets in the 
external phase depended on the agitation speed of the 
systems. As stirring rate increased, the size of 
microparticles was reduced. For example when the rate 
of stirring was increased from 400 to 600 rpm, the mean 
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 particle size was decreased from 375.93±1.53 (F5-2) to 
300.88±1.86 µm ((F5-3).   
The effect of the ester sucrose concentration on the mean 
particle size of theophylline microspheres was shown in 
Table 3. The results showed that decreasing the amount 
of ester sucrose ((F5-4) increases the particle size of 
microspheres. The results indicated that reduction of 
volume of dispersing medium increased of particle size 
of microspheres.  
 
In vitro release studies 
The release profile of theophylline from Eudagit RS 100 
microspheres is illustrated in Figure 5.  
The effect of drug: polymer ratio on the drug release 
from microspheres depended on the polymer 
concentration of the prepared devices which indicates 
that the release rate is decreased with increasing the 
amount of the polymer (F5).
18
 
 
Figure 3. X-ray diffraction of anhydrous theophylline (a), 
Eudragit RS100 (b), physical mixture F5 (c), F1 (d), F2 (e), F3 (f), 
F4 (g) and F3 (h). 
 
Table 3. Effect of drug: polymer ratio, stirring rate, Emulsifier and dispersing medium on the drug content, production yield and particle size 
of anhydrous theophylline microspheres 
Parameter 
Characteristics 
Formulation 
code 
Process 
variable 
Productionyi
eld(%±SD) 
Theoreticaldrug 
content(%) 
Mean 
drugentrapped 
(%) 
Mean particle 
Size (µm ± SD) 
Drug loading 
efficiency(%±SD) 
Polymer: 
Drugratio 
F1 
F2 
F3 
F4 
*F5 
2:1 
3:1 
4:1 
5:1 
6:1 
90.50±2.24   
91.83±3.24 
99.63±3.08 
99.90±3.13 
92.83±4.12 
33.33 
25 
20 
16.67 
14.29 
25.3±0.65 
17.48±3.93 
14.01±2.53 
10.53±4.13 
8.67±1.32 
352.76±1.68 
286.08±1.67 
248.09±1.59 
225.57±1.36 
205.93±1.53 
75.92±12.3 
69.91±1.90 
70.05±12.6 
63.18±15.7 
60.67±9.50 
 
Stirring 
rate(rpm) 
F5-1 
*F5-2 
F5-3 
200 
400 
600 
- 
92.83±4.12 
6.19 ±91.65 
- 
14.29 
14.29 
- 
8.67±1.32 
0.27±13.40 
- 
375.93±1.53 
300.88±1.86 
- 
60.67±9.5 
95.74±1.59 
 
Emulsifier       
concentration 
(%) 
F5-4 
*F5-5 
F5-6 
1 
3 
5 
1.24 ±81.01 
92.83±4.12 
6.59  ± 92.83 
14.29 
14.29 
14.29 
0.32±7.61 
8.67±1.32 
8.04±0.87 
1.69 ±    398.88 
375.93±1.53 
234.75  ± 1.68 
54.36±1.88 
60.67±9.50 
57.43±0.05 
 
Volume of 
dispersing 
medium(ml) 
F5-7 
*F5-8 
F5-9 
100 
200 
300 
1.24±94.43 
92.83±4.12 
77.47±3.22 
14.29 
14.29 
14.29 
8.57±1.19 
8.67±1.32 
10.05±0.48 
1.71 ±    303.76 
375.93±1.53 
219.36±1.76 
59.97±0.57 
60.67±9.50 
70.36±2.80 
 
The release rates of larger microspheres (F5 and 
theophylline SR tablet) were slower than that of smaller 
microspheres (F1, F2, F3 and F4) and had a burst release 
in the initial phase (Figure 5). Drug release rates were 
increased with increasing amounts of theophylline in the 
formulation (with low polymer concentration from F5 to 
F1).  Higher level of theophylline corresponding to lower 
level of the polymer in the formulation resulted in an 
increase in the drug release rate. Burst effect of 6:1 
polymer: drug formulation was lower than that of other 
formulation (p<0.05). Statistical analysis of data was 
performed by comparing the DE (dissolution efficiency), 
t50% (dissolution time for 50% fractions of drug); 
''similarity factor, f2 (used to compare multipoint 
dissolution profiles)'' (Table 4).
13
 
The change of stirring speed emulsification process also 
influenced the drug release profile as shown in Figure 6.  
Higher agitation rates resulted in slower drug release (as 
F5-3).  At high concentration of ester sucrose a faster 
drug release was observed (Figure 7). At various 
volumes of dispersing medium, there is no difference on 
the drug released. The faster drug release and higher 
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drug entrapment was observed from microspheres 
prepared using larger volume of processing medium at 
pH 1.2 and 7.4 (Figure 8). Mathematical models have 
been used extensively for the parametric representation 
of dissolution data.
2,14
 The fit parameters to Higuchi, 
first-order, Peppas and zero-order kinetics were 
determined (Table 5). High correlation to Higuchi and 
first order kinetics was observed for F5 and theophylline 
SR® tablet, respectively. 
 
 
Figure 4. FTIR spectrum of anhydrous theophylline (a), cellulose 
acetate butyrate (b), physical mixture F5 (c), F1 (d), F2 (e), F3 (f), 
F4 (g) and F3 (h). 
 
Discussion 
The high solubility of the drug prevented the preparation 
of saturated solutions in the solvents.  In Mehta’s 
study
10
, polymers having high solubility in methanol 
stayed longer in the semi-solid state, the dispersed phase 
became more concentrated before it completely 
solidified, resulting in denser microparticles. On the 
other hand, Bodmeier and co-workers found that 
methylene chloride result in higher encapsulation 
efficiency compared to other solvents.
15
 In order to 
justify this discrepancy, the authors point out that 
acetonitrile is more soluble in water than methylen 
chloride. Knowing that theophylline is slightly soluble in 
methylen chloride, also acetonitrile is water-miscible 
solvent (non-solvent for Eudragit RS 100) it can be 
assumed that it plays a dual function in facilitating the 
polymer precipitation. The high solubility allowed 
relatively fast mass-transfer between the dispersed and 
the continuous phases and leads to fast precipitation of 
the polymer. The importance of solubility of the organic 
solvent was also confirmed by the fact that the addition 
of water-miscible co-solvents such as acetone, methanol, 
ethyl acetate, or dimethyl sulfoxide (DMSO), contributes 
to increased encapsulation efficiency.
15
 
 
Table 4. Comparision of various release characteristics of 
anhydrous theophylline from different microsphere formulations, 
physical mixture and teophylline SR® tablet 
Formulation aQ2 
bQ8 
ct 
50% 
(h) 
dDE 
Similarity 
factor 
F1 63.3±3.6 100.19±0.16 0.75 89.21 27.29 
F2 65.3±0.3 99.11±0.19 0.5 95.08 20.07 
F3 54.9±0.2 92.64±1.41 0.5 89.47 22.95 
F4 50.6±0.5 94.52±0.23 2 88.39 24.63 
F5 48.5±3.2 92.80±1.85 2 91.28 27.32 
PM 64.8±1.4 102.20±1.54 0.5 96.36 21.63 
Theophylline 
SR® 
12.8±1.5 80.86±5.74 5 73.94 100 
 
Generally, the encapsulation efficiencies of the 
microspheres prepared with Eudragit RS100 were high; 
this can be attributed to the low content of the 
ammonium group which facilitates the diffusion of the 
entrapped drug to the surrounding medium during 
formation of the microspheres. 
The surface of microspheres appeared spherical but 
rough and there were several cracks on the surfaces. It is 
observed that in spite of using the constant 
polymer/solvent ratio, the depth of cracks on the surface 
of microspheres become greater while the polymer 
amount of formulation was increased. This can be 
attributed to the increasing volume of dispersing 
medium, i.e. liquid paraffin (Table 1) resulting from the 
extended diffusion of organic solvent to the dispersing 
medium. Similar observation has been reported for 
verapamil microspheres.
2
 
The microsphere size distribution depended on the 
droplet size of the emulsion and on the extent of 
aggregation between forming microspheres. Polymer 
deposition within the droplets occurred through the 
removal of the polymer solvent. The polymer solvent 
system, acetone and methanol, were soluble in liquid 
paraffin to a limited extent. Upon emulsification of the 
polymer solution some of the acetone and methanol 
migrate into the liquid paraffin external phase. The rate 
of acetone and methanol transfer depended on the size of 
the emulsion droplets, since partitioning is a surface area 
phenomenon. Therefore the rate of solvent removal was 
dependent upon the rate of solvent portioning and 
evaporation.
16
 
The X-ray spectrum showed that addition of amorphous 
polymer decreased the degree of crystallinity of the drug 
(Figure 2). The DSC thermogram demonstrated no 
abrupt or drastic change in the thermal behavior of rather 
the drug or polymer which indicates no possible drug-
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 polymer interaction (Figure 3). However in the 
thermogram of the microparticles there was no 
endothermic peak of the drug melting, suggesting the 
amorphous state of the drug in the microparticles. It was 
observed that sucrose stearate prevents coalescence in 
the emulsion system by the formation of a protective 
film around the droplets (Table 3). This may be due to 
the formation of large-size microspheres at lower 
emulsifier levels, which provided less surface area for 
drug escape to the external processing medium. These 
results agreed well with Kawata et al., and Yüksel et 
al..
7, 8
 
 
 
Figure 5. Cumulative percent release of anhydrous theophylline 
from microspheres prepared with different polymer-to-drug ratio, 
physical mixture and teophylline SR® tablet  
Ester sucrose, were used to modify solvent diffusion 
rates in the emulsion for the preparation of 
microspheres.
7,18 
It has been reported that ester sucrose 
ensured the diffusion of solvent in emulsion droplets 
toward outer phase, prohibiting molecular interaction 
between the drug and inner phase solvent. Finally, the 
drug and the polymer are solidifies in the form of 
microspheres due to their decreasing 
solubilities.
7,19
Increasing the amount of ester sucrose 
decreased the particle size of microspheres, because the 
globules of emulsion were divided to smaller particles. 
On the other hand the particle size of microspheres was 
proportional to the viscosity of the dispersing medium.  
 
 
Figure 6. Cumulative percent release of Tolmetin sodium from 
microspheres F5 prepared with different rates of stirring 
The incorporation efficiencies of theophylline in the 
microspheres were between 60-75%. The results showed 
that when the stirring rate was increased to 600 rpm, the 
loading efficiency increased. Increasing the amount of 
emulsifier from 1-5% did not affect the drug content 
(p>0.05). However decreasing ester sucrose 
concentration (from 3% to 1%) decreased production 
yield (p<0.05). Higher entrapment of drug was noticed 
when a lower concentration of ester sucrose was used 
(Table 3). The volume of processing medium (O2) 
influenced the entrapment efficiency of the microspheres 
(Table3). As the volume of processing medium was 
decreased from 200 ml to 100 ml, the entrapment 
efficiency did not change (p>0.05). The results also 
showed that when volume of dispersing medium was 
increased from 200 ml to 300 ml, the entrapment 
efficiency significantly decreased from 60% to 70% 
(p<0.05).  As the volume of processing medium was 
increased, the emulsion droplets probably moved freely 
in the medium, thus reducing collision induced 
aggregation and yielding small and uniform 
microspheres. This could also be the reason for higher 
drug extraction into the processing medium resulting in 
lower entrapment efficiency.  
 
 
Figure 7. Cumulative percent release of Tolmetin sodium from 
microspheres F5 prepared with different emulsifier concentration. 
This can be explained by a decreased amount of drug 
present close to the surface and also by the fact that the 
amount of uncoated drug decreases with higher polymer 
concentration (Figure 5).
19
 However, when particles are 
prepared by O1/O2 method, water-soluble drugs do not 
have tendency to migrate to the organic medium, thereby 
concentrating at the surface of the particles and resulting 
in the burst effect.
21
 Moreover, the burst release could 
also be explained by the imperfect encapsulation of the 
drug inside microparticles, resulting from the unstable 
nature of the emulsion droplets during the solvent 
removal step. This potential instability may cause a part 
of the loaded drug to relocate at the microparticle 
surface, thereby rapidly released.
9
The corresponding 
release rates are also reduced by increasing polymer 
concentrations (Figure 5). This phenomenon can be 
attributed to the increased thickness of the polymer 
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matrix surrounding the drug. Similar behavior was 
observed in verapamil prepared with Eudragit RS100.
2
 
In most cases, a biphasic dissolution profile was 
observed, the initial rapid drug leakage generally ended 
very; for the remaining time, nearly linear behavior was 
observed. It can be supposed that the first portion of the 
curves is due to theophylline dissolution, which starts 
immediately after the beginning of the test for the 
portion of drug on the surface of microparticles. After 
such a phase, two phenomena can combine in enhancing 
in the diffusion of the remaining dispersed drug into the 
bulk phase as well as the formation of pores within the 
matrix due to the initial drug dissolution; particle wetting 
and swelling which enhances the permeability of the 
polymer to the drug 
22
 (Figure 5).  
 
 
Figure 8. Cumulative percent release of Tolmetin sodium from 
microspheres F5 prepared with different paraffin amount. 
Table 5. Fitting parameters of the in vitro release data to various release kinetic models 
Order F1 F2 F3 F4 F5 
Tablet 
SR 
Physical Mixture 
Zero 
f=kt 
K 0.0006 0.0003 0.0003 0.0003 0.0008 0.0007 0.0003 
RSQ 0.9385 0.4461 0.4440 0.4631 0.9114 0.6905 0.5558 
D(SS )% 698.31 980.35 880.56 868.12 701.15 457.99 897.21 
First 
Ln(1-f)=kt 
k 0.0056 0.0057 0.0018 0.0018 0.0031 0.0032 0.0061 
RSQ 0.9074 0.9110 0.6101 0.6629 0.8517 0.9932 0.9772 
D(SS )  %  251.30 269.85 581.55 564.91 373.01 747.72 318.13 
PeppasLnf=lnk+blnt 
b 0.5267 0.2840 0.0780 0.0501 0.2076 1.2454 0.2245 
k 0.1877 0.1905 0.3836 0.3974 0.1894 0.0004 0.2699 
RSQ 0.9624 0.9999 0.8360 0.9741 0.8757 0.9723 0.9476 
D(SS)  %  8.4930 0.2167 6.2954 1.6340 23.9331 96.6275 6.6756 
Higuchi 
f=kt0.5 
k 0.0444 0.0171 0.0170 0.0183 0.0381 0.0339 0.0157 
RSQ 0.9524 0.6556 0.6682 0.6852 0.9344 0.8740 0.7825 
D(SS)  %  231.29 684.80 660.99 623.66 225.05 1399.92 727.68 
 
 
 
Dissolution efficiency (DE) was calculated from the area 
under the dissolution curve at time and expressed as 
percentage of the area of the rectangle described by 
100% dissolution in the same time. F5 microsphere and 
theophylline SR
®
 tablet showed lower dissolution 
efficiency. Theophylline SR 
®
 tablet and F5 had lower 
release in comparison with microspheres (p< 0.05), 
(Table 4 & Figure 5). There is no similarity between F5 
and theophylline SR
®
 tablet. 
The data obtained were fitted to Korsemeyer-Peppas 
model in order to find out n value, which describes the 
drug release mechanism (Table 5). The n value of 
microspheres of different drug to polymer ratio was 
between 0.21, indicating that the mechanism of the drug 
release was diffusion controlled.  
 
Conclusion 
Theophylline loaded microspheres were prepared by 
solvent evaporation method (O1/O2). The results of this 
study shows that increased polymer concentration could 
slow down dissolution rate, decrease particle size, and 
influence the surface properties of microspheres. The 
entrapment efficiency was at range of 60-75% for all 
formulations. The encapsulation efficiency was more 
influenced with changing the stirring speed as well as 
dispersing medium volume. It was observed that at 
higher polymer concentration, the mean particle size of 
the microspheres is low but increasing the stirring speed 
and emulsifier content, resulted in smaller mean particle 
size of microspheres. Drug release from theophylline 
microspheres followed Higuchi model. It was suggested 
that mechanism of drug release from microspheres was 
diffusion controlled. Controlled release with initial burst 
release (loading dose) achieved with these formulations 
may reduce dose frequency and side effects as well as 
improved patient compliance. 
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